The section entitled Complete data sheet is not available in English for this substance. Consult the French version.

Identification

Description


Formule moléculaire brute : C3H2ClF5O

Principaux synonymes

Noms français :

  • 2-CHLORO-1,1,2-TRIFLUOROETHYL DIFLUOROMETHYL ETHER
  • 2-CHLORO-1-(DIFLUOROMETHOXY)-1,1,2-TRIFLUOROETHANE
  • Chloro-2 difluorométhoxy-1 trifluoro-1,1,2 éthane
  • Enflurane
  • ETHANE, 1-CHLORO-1-(DIFLUOROMETHOXY)-1,1,2-TRIFLUORO-
  • ETHANE, 2-CHLORO-1-(DIFLUOROMETHOXY)-1,1,2-TRIFLUORO-
  • ETHER, 2-CHLORO-1,1,2-TRIFLUOROETHYL DIFLUOROMETHYL

Noms anglais :

  • Enflurane
Utilisation et sources d'émission

Agent anesthésiant

Références

  • ▲1.  Budavari, S. et O'Neil, M., The Merck index : an encyclopedia of chemicals, drugs, and biologicals. 12ème éd. Rahway (N.J.) : Merck. (1996). [RM-403001]
  • ▲2.  National Institute for Occupational Safety and Health, NIOSH pocket guide to chemical hazards. Washington, D.C. : NIOSH. (1998-). [RM-514001]   http://www.cdc.gov/niosh/npg/npg.html
  • ▲3.  Drolet, D. et Beauchamp, G, Guide d'échantillonnage des contaminants de l'air en milieu de travail. Études et recherches / Guide technique, 8ème éd. revue et mise à jour. Montréal : IRSST. (2012). T-06. [MO-220007]   http://www.irsst.qc.ca
    http://www.irsst.qc.ca/files/documents/PubIRSST/t-06.pdf
  • ▲4.  Giroud, J.-P., Mathé, G. et Meyniel, G., Pharmacologie clinique : bases de la thérapeutique. 2e éd. Paris : Expansion Scientifique Française. (1988). [RM-414008]
  • ▲5.  Dale, O. et Brown, B.R., «Clinical pharmacokinetics of the inhalational anaesthetics.» Clinical Pharmacokinetics. Vol. 12, p. 145-167. (1987).
  • ▲6.  Imbriani, M. et al., «Biological monitoring of occupational exposure to enfluran (ethrane) in operating room personnel.» Archives of Environmental Health. Vol. 49, no. 2, p. 135-140. (1994).
  • ▲7.  Damia, G. et Torri, G., «Caractéristiques physico-chimiques, cinétique d'absorption et d'élimination, technique d'emploi de l'enflurane.» Ann. Anesth. Franç. Vol. XVI, p. 573-586. (1975).
  • ▲8.  Cousins, M.J. et Mazze, R.I., «Biotransformation of enflurane (ethrane) and isoflurane (forane).» Int. Anesthesiol. Clin. Vol. 12, no. 2, p. 111-119. (1974).
  • ▲9.  Miller, M.S. et Gandolfi, A.J., «Enflurane biotransformation in humans.» Life Sciences. Vol. 27, p. 1465-1468. (1980).
  • ▲10.  Sakai, T. et Takaori, M., «Biodegradation of halothane, enflurane and methoxyflurane.» British Journal of Anaesthesia. Vol. 50, p. 785-791. (1978).
  • ▲11.  Archives des maladies professionnelles, de médecine du travail et de sécurité sociale. Vol. 49, 4. (1988). [AP-022494]
  • ▲12.  Strum, D.P. et al., «Age affects the phamacokinetics of inhaled anesthetics in humans.» Anesthesia and Analgesia. Vol. 73, p. 310-318. (1991).
  • ▲13.  Waskell, L., Metabolism of the volatile anesthetics. New York : Raven Press. (1994).
  • ▲14.  Van Dyke, R.A., Toxic metabolites from biotransformation : major organ damage. International Anesthesiology Clinics, Vol. 19. Boston : Little, Brown and Company. (1981).
  • ▲15.  Schwettmann, R.S. et Casterline, C.L., «Delayed asthmatic response following occupational exposure to enflurane.» Anesthesiology. Vol. 44, no. 2, p. 166-169. (1976).
  • ▲16.  Ramazzotto, L.J. et Carlin, R.D., «Ethrane teratogenicity - a preliminary report.» Journal of Dental Research. Vol. 57, p. 289. (1978).
  • ▲17.  Mazze, R.I. et al., «Reproductive and teratogenic effects of nitrous oxide, halothane, isoflurane, and enflurane in Sprague-Dawley rats.» Anesthesiology. Vol. 64, p. 339-344. (1986).
  • ▲18.  Abboud, T.K. et al., «Comparative maternal and neonatal effects of halothane and enflurane for cesarean section.» Acta Anesthesiologica Scandinavica. Vol. 29, p. 663-668. (1985).
  • ▲19.  Natsume, M. et al., «Teratogenicity caused by halothane, enflurane, and sevoflurane, and changes depending on O2 concentration.» Teratology. Vol. 42, no. 6, p. 30A. (1990).
  • ▲20.  Monk, S.J. et al., «Is chronic exposure to enflurane teratogenic or toxic at 200 ppm : A study in rats.» British Journal of Anaesthesia. Vol. 54, p. 1139-1140. (1982).
  • ▲21.  Green, C.J. et al., «Chronic exposure of rats to enflurane 200 ppm: No evidence of toxicity or teratogenicity.» British Journal of Anaesthesia. Vol. 54, p. 1097-1104. (1982).
  • ▲22.  Halsey, M.J. et al., «Maternal and paternal chronic exposure to enflurane and halothane : fetal and histological changes in the rat.» British Journal of Anaesthesia. Vol. 53, p. 203-215. (1981).
  • ▲23.  Strout, C.D. et al., «Effects of subanesthetic concentrations of enflurane on rat pregnancy and early development.» Environmental Health Perspectives. Vol. 21, p. 211-214. (1977).
  • ▲24.  Wharton, R.S., Mazze, R.I. et Wilson, A.I., «Reproduction and fetal development in mice chronically exposed to enflurane.» Anesthesiology. Vol. 54, p. 505-510. (1981).
  • ▲25.  Pope, W.D.B. et Persaud, T.V.N., «Foetal growth retardation in the rat following chronic exposure to the inhalation anesthetic enflurane.» Experientia. Vol. 34, no. 10, p. 1332-1333. (1978).
  • ▲26.  Saito, N., Urakawa, M. et Ito, R., «Influence of enflurane on fetus and growth after birth in mice and rats.» Oyo Yakuri (Pharmacometrics). Vol. 8, p. 1269-1276. (1974).
  • ▲27.  Peters, M.A. et Hudson, P.M., «Postnatal development and behavior in offspring of enflurane exposed pregnant rats.» Archuives Internationales de Pharmacodynamie et de Therapie. Vol. 256, p. 134-144. (1982).
  • ▲28.  Health Council of the Netherlands : Dutch Expert Committee for Compounds toxic to reproduction, Enflurane : Evaluation of the effects on reproduction, recommendation for classification. Vol. 12 OSH. The Hague : Health Council of the Netherlands. (2002).   http://www.gezondheidsraad.nl/en/publications/enflurane
  • ▲29.  Ott, M. G., Diller, W. F. et Jolly, A. T., «Respiratory effects of toluene diisocyanate in the workplace: a discussion of exposure-response relationships.» Critical Reviews in Toxicology. Vol. 33, no. 1, p. 1-59. (2003). [AP-001046]
  • ▲30.  Cameron, A.M. et al., «Inhalation of enflurane and halothane at subanesthetic concentrations and effects on circulating serum testosterone, luteinizing hormone and follicle-stimulating hormone in the male rats..» Toxicology Letters. Vol. 19, p. 333-338. (1983).
  • ▲31.  Baden, J.M. et al., «Metabolic and toxicologic studies with enflurane in Swiss/ICR mice.» Journal of Environmental Pathology and Toxicology. Vol. 4, p. 293-303. (1980).
  • ▲32.  Baden, J.M. et al., «Lack of toxicity of enflurane on male reproductive organs in mice.» Anesthesia and Analgesia. Vol. 61, p. 19-22. (1982).
  • ▲33.  Eger, E.I. et al., «A test of the carcinogenicity of enflurane, isoflurane, halothane, methoxyflurane, and nitrous oxide in mice.» Anesthesia and Analgesia. Vol. 57, p. 678-694. (1978).
  • ▲34.  Baden, Jeffrey M., Egbert, Barbara et Mazze, Richard I., «Carcinogen bioassay of enflurane in mice.» Anesthesiology. Vol. 56, p. 9-13. (1982). [ap-012976]
  • ▲35.  IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Overall evaluations of carcinogenicity : an updating of IARC monographs volumes 1-42. IARC monographs on the evaluation of carcinogenic risks to humans, Supplement 7. Lyon : International Agency for Research on Cancer. (1987). [MO-011531]   http://www.iarc.fr ou
    http://monographs.iarc.fr/
  • ▲36.  IARC Working Group on the Evaluation of Carcinogenic Risks of Chemical to Man, Cadmium, nickel, some epoxides, miscellaneous industrial chemicals and general considerations on volatile anaesthetics. IARC monographs on the evaluation of carcinogenic risks of chemical to man, Vol. 11. Lyon : International Agency for Research on Cancer. (1976). [MO-023436]   http://www.iarc.fr
  • ▲37.  American Conference of Governmental Industrial Hygienists, 2017 TLVs® and BEIs® : threshold limit values for chemical substances and physical agents and biological exposure indices. Cincinnati (OH) : ACGIH. (2017). Publication 0114. [NO-003164]   http://www.acgih.org
  • ▲38.  Règlement sur la santé et la sécurité du travail [S-2.1, r. 13]. Québec : Éditeur officiel du Québec. [RJ-510071]   http://www2.publicationsduquebec.gouv.qc.ca/dynamicSearch/telecharge.php?type=3&file=/S_2_1/S2_1R13.HTM (À jour au 1er décembre 2012)
    http://www3.publicationsduquebec.gouv.qc.ca/loisreglements.fr.html
  • ▲39.  National Institute for Occupational Safety and Health, RTECS (Registry of Toxic Effects of Chemical Substances). Hamilton (Ont) : Canadian Centre for Occupational Health and Safety.   http://ccinfoweb.ccohs.ca/rtecs/search.html
  • ▲40.  Centre canadien d'hygiène et de sécurité au travail, CHEMINFO, Hamilton, Ont. : Canadian Centre for Occupational Health and Safety   http://ccinfoweb.ccohs.ca/cheminfo/search.html
  • ▲41.  IPCS (International Programme on Chemical Safety), Enflurane. ICSC#0887. (2002).   http://www.inchem.org/documents/icsc/icsc/eics0887.htm

La cote entre [ ] provient de la banque ISST du Centre de documentation de la CSST.